Kelly focuses on general business litigation matters in state and federal courts. She has experience in all phases of litigation, including discovery, eDiscovery, hearing and trial preparation, and trial.
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
December 20, 2022
A Cooley team advised Horizon Therapeutics, a specialty biopharmaceutical company, on its agreement to be acquired by Amgen. The approximately $28 billion merger would represent the third-largest all-cash transaction in the pharmaceutical sector in history and the biggest healthcare deal of 2022.